ACM
WVE icon

Aquatic Capital Management’s Wave Life Sciences WVE Stock Holding History

Aquatic Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-323,573
Closed -$2.35M – 1800
2026
Q1 		$2.35M Buy
+323,573
New +$4.22M 0.07% 340
2025
Q2 		– Sell
-71,741
Closed -$580K – 1594
2025
Q1 		$580K Sell
71,741
-10,277
-13% -$112K 0.01% 729
2024
Q4 		$1.01M Buy
+82,018
New +$1.09M 0.03% 539
2022
Q2 		– Sell
-1,100
Closed -$2K – 1609
2022
Q1 		$2K Buy
+1,100
New +$2.69K ﹤0.01% 988

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Aquatic Capital Management's WVE Position: Q2 2026 in Review

Aquatic Capital Management sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 323,573 shares — an estimated $2.35M sold.

Aquatic Capital Management first reported a position in WVE in Q1 2022 and held it in 4 quarters. The position peaked at $2.35M in Q1 2026. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Aquatic Capital Management reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 323,573 Wave Life Sciences shares in Q2 2026, an estimated $2.35M.
  • Aquatic Capital Management first reported a position in Wave Life Sciences in Q1 2022 and held it in 4 quarters.
  • Aquatic Capital Management's Wave Life Sciences position peaked at $2.35M in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.